Defining the physiology of E. coli O157:H7 in cattle to develop phage-based interventions

定义牛体内大肠杆菌 O157:H7 的生理学以开发基于噬菌体的干预措施

基本信息

  • 批准号:
    BB/X007022/1
  • 负责人:
  • 金额:
    $ 62.41万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2023
  • 资助国家:
    英国
  • 起止时间:
    2023 至 无数据
  • 项目状态:
    未结题

项目摘要

Escherichia coli O157:H7 (O157) is a zoonotic bacterial pathogen which colonises cattle but does not cause disease in the bovine host. However, if the bacteria passes in to the food chain and infects a human host then it can result in severe health complications and sometimes death. If we can prevent the bacteria from colonising and persisting in cattle then we would reduce the burden of this pathogen entering the food chain. This is especially important in the case of food that won't be cooked before consumption such as unpasteurised cheese. Interventions, particularly vaccines, have been trialled but with limited commercial success. We propose to develop a bacteriophage (phage) treatment that will selectively remove O157 bacteria from the cattle. Phage are viruses that only infect and kill bacteria. They are very specific and their life cycle is dependent on recognising a receptor, often a protein, on the outside of their bacterial host. Once they have found the receptor they can attach, inject their DNA, replicate inside the bacterial cell and then burst out killing the bacterial cell in the process. Phage and bacteria are continually at war with each other in nature and so both continually evolve to be able to resist infection (bacteria) and to be able to reinfect (phage). We can select phage in the laboratory that can infect and kill O157 strains with lab culture conditions. However, in the host the bacteria will be in a different physiological state to that in nutrient rich media in the laboratory. This means the specific receptors on their surface may be different in these different nutrient limited conditions and when the bacteria are attached to epithelial cells and growing more slowly. Phage intervention has previously been attempted as a control for O157 in cattle but with limited success. We have evidence this is because the physiological state of the bacteria in the host is too different from the lab conditions that the phage were selected in. We propose that by understanding which receptors are expressed by the bacteria on their surface when they are in the bovine host we can select phage that will be active when used as an intervention strategy to remove/reduce O157 from cattle and therefore protect the food chain. With a greater understanding of the physiology of the bacteria in its host we can develop models in the laboratory that better represent the 'in host' conditions. We can then use these lab models to test phage activity and create phage combinations that can be tested in cattle colonised with O157. This will not only address an unmet need in O157 control but will be an exemplar for other bacterial infections that could be targeted by phage therapy including antibiotic resistant infections.
大肠杆菌O 157:H7(O 157)是一种人畜共患细菌病原体,在牛宿主中定植但不会引起疾病。然而,如果细菌进入食物链并感染人类宿主,则可能导致严重的健康并发症,有时甚至死亡。如果我们能够防止细菌在牛体内定植和持续存在,那么我们将减少这种病原体进入食物链的负担。这一点对于那些在食用前不会烹饪的食物尤其重要,比如未经高温消毒的奶酪。干预措施,特别是疫苗,已经进行了试验,但商业成功有限。我们建议开发一种噬菌体(噬菌体)治疗,将选择性地从牛中去除O 157细菌。噬菌体是只感染和杀死细菌的病毒。它们非常特异,它们的生命周期依赖于识别细菌宿主外部的受体,通常是蛋白质。一旦它们找到受体,它们就可以附着,注入它们的DNA,在细菌细胞内复制,然后在这个过程中杀死细菌细胞。噬菌体和细菌在自然界中不断地相互战争,因此两者都不断进化以能够抵抗感染(细菌)并能够再次感染(噬菌体)。在实验室培养条件下,可以筛选出能感染和杀灭O 157菌株的噬菌体。然而,在宿主中,细菌将处于与实验室中营养丰富的培养基中不同的生理状态。这意味着它们表面上的特异性受体在这些不同的营养限制条件下可能是不同的,当细菌附着在上皮细胞上并且生长得更慢时。噬菌体干预以前曾试图作为控制牛O 157,但成功有限。我们有证据表明,这是因为宿主中细菌的生理状态与噬菌体选择的实验室条件差异太大。我们建议,通过了解哪些受体表达的细菌在其表面上,当他们在牛宿主,我们可以选择噬菌体,将被用作干预策略时,以消除/减少牛O 157,从而保护食物链。随着对宿主中细菌生理学的更深入了解,我们可以在实验室中开发出更好地代表“宿主”条件的模型。然后,我们可以使用这些实验室模型来测试噬菌体活性,并创建可以在O 157定殖的牛中进行测试的噬菌体组合。这不仅解决了O 157控制中未满足的需求,而且将成为噬菌体治疗可靶向的其他细菌感染的范例,包括抗生素耐药性感染。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David Gally其他文献

David Gally的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David Gally', 18)}}的其他基金

Cattle farming practices and the emergence of Escherichia coli O157 (Stx2a+): an international workshop award with INTA Argentina
养牛实践和大肠杆菌 O157 (Stx2a) 的出现:与 INTA 阿根廷共同颁发的国际研讨会奖
  • 批准号:
    BB/T019743/1
  • 财政年份:
    2023
  • 资助金额:
    $ 62.41万
  • 项目类别:
    Research Grant
Machine-learning to predict and understand the zoonotic threat of E. coli O157 isolates
机器学习预测和了解大肠杆菌 O157 菌株的人畜共患威胁
  • 批准号:
    BB/P02095X/1
  • 财政年份:
    2017
  • 资助金额:
    $ 62.41万
  • 项目类别:
    Research Grant
Tackling Enterohaemorrhagic E. coli infection across continents
应对各大洲的肠出血性大肠杆菌感染
  • 批准号:
    BB/L026740/1
  • 财政年份:
    2014
  • 资助金额:
    $ 62.41万
  • 项目类别:
    Research Grant
Defining the molecular basis of H7 flagellin as an adhesin and mucosal adjuvant for vaccine development
定义 H7 鞭毛蛋白作为疫苗开发的粘附素和粘膜佐剂的分子基础
  • 批准号:
    BB/I011625/1
  • 财政年份:
    2012
  • 资助金额:
    $ 62.41万
  • 项目类别:
    Research Grant

相似海外基金

Mechanisms underlying diarrhea and gut inflammation mediated by Enterotoxigenic and Enteropathogenic E. coli
产肠毒素和致病性大肠杆菌介导的腹泻和肠道炎症的机制
  • 批准号:
    10674072
  • 财政年份:
    2023
  • 资助金额:
    $ 62.41万
  • 项目类别:
Characterization of the RRS: a new chromosomal structural element in E. coli
RRS 的表征:大肠杆菌中的一种新染色体结构元件
  • 批准号:
    10752809
  • 财政年份:
    2023
  • 资助金额:
    $ 62.41万
  • 项目类别:
Investigating the impact of ESBL E. coli colonization on infant microbiome
研究 ESBL 大肠杆菌定植对婴儿微生物组的影响
  • 批准号:
    10727040
  • 财政年份:
    2023
  • 资助金额:
    $ 62.41万
  • 项目类别:
Defining the in vivo physiology of E. coli O157:H7 in cattle to improve phage-based interventions
定义牛体内大肠杆菌 O157:H7 的生理学,以改善基于噬菌体的干预措施
  • 批准号:
    BB/X006743/1
  • 财政年份:
    2023
  • 资助金额:
    $ 62.41万
  • 项目类别:
    Research Grant
Role of Metallothionein 1 E in the protection of cystic fibrosis-related diabetes
金属硫蛋白 1 E 在保护囊性纤维化相关糖尿病中的作用
  • 批准号:
    10714873
  • 财政年份:
    2023
  • 资助金额:
    $ 62.41万
  • 项目类别:
Functional consequences of bacterial-fungal dysbiosis in E/VLBW infants
E/VLBW 婴儿细菌-真菌失调的功能后果
  • 批准号:
    10373520
  • 财政年份:
    2022
  • 资助金额:
    $ 62.41万
  • 项目类别:
Functional consequences of bacterial-fungal dysbiosis in E/VLBW infants
E/VLBW 婴儿细菌-真菌失调的功能后果
  • 批准号:
    10569645
  • 财政年份:
    2022
  • 资助金额:
    $ 62.41万
  • 项目类别:
Systematic identification of cardiotoxic e-cigarette flavorants
系统鉴定心脏毒性电子烟香料
  • 批准号:
    10610732
  • 财政年份:
    2022
  • 资助金额:
    $ 62.41万
  • 项目类别:
Effects of Chromosomal Topology and Organization on E. coli Gene Expression
染色体拓扑和组织对大肠杆菌基因表达的影响
  • 批准号:
    10744700
  • 财政年份:
    2022
  • 资助金额:
    $ 62.41万
  • 项目类别:
Core E: Cellular and Organismic Systems for Antiviral Testing
核心 E:用于抗病毒测试的细胞和有机体系统
  • 批准号:
    10522809
  • 财政年份:
    2022
  • 资助金额:
    $ 62.41万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了